Tempus AI stock is cheap as Murrey Math Lines points to more gains

Group 1 - Tempus AI stock price surged to a record high following a major breakthrough from the Food and Drug Administration (FDA) [1] - The breakthrough is expected to significantly enhance the company's position in the healthcare-focused artificial intelligence sector [1] - This development reflects growing investor confidence in the potential of AI technologies within the healthcare industry [1] Group 2 - The FDA's announcement is seen as a pivotal moment for Tempus AI, potentially leading to increased market share and revenue growth [1] - The healthcare AI market is experiencing rapid advancements, with companies like Tempus AI at the forefront of innovation [1] - Investors are closely monitoring the implications of regulatory approvals on the overall performance of AI companies in the healthcare space [1]